Benzinga's Top #PreMarket Losers
May 27, 2014 at 08:12 AM EDT
Durata Therapeutics (NASDAQ: DRTX) dipped 11.19% to $15.00 in pre-market trading. Durata Therapeutics confirmed the FDA approval of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.